US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
AstraZeneca
Brian L Heiss; Elaine Chang; Xin Gao; Tien Truong; Michael H Brave; Erik Bloomquist; Ankit Shah; Salaheldin Hamed; Jeffrey Kraft; Haw-Jyh Chiu; Tiffany K Ricks; Amy Tilley; William F Pierce; Liuya Tang; Abdelrahmman Abukhdeir; Shyam Kalavar; Reena Philip; Shenghui Tang; Richard Pazdur; Laleh Amiri-Kordestani; Paul G Kluetz; Daniel L Suzman